The ratio evolves dynamically: tumor cells and other components in the TME can produce inhibitory factors such as anti-inflammatory cytokines, interleukins 10 and 4 (IL-10 and IL-4), Transforming Growth Factor-beta (TGF-β) which favor the polarization of antitumor immune cells into protumor ones. Here, IL10 is linked to neoplasm.